Loading clinical trials...
Loading clinical trials...
Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 in Bordeaux Urban Area, June 2011: Evaluation of Diagnostic, Prognostic and Pathophysiological Data
Conditions
Interventions
HUS standard coverage care (including in ICU)
Locations
1
France
Service de Néphrologie, transplantation dialyse - Hôpital Pellegrin
Bordeaux, France
Start Date
July 1, 2011
Primary Completion Date
March 1, 2012
Completion Date
March 1, 2012
Last Updated
November 20, 2012
NCT06389474
NCT05219110
NCT03869593
NCT02729116
NCT01194973
NCT02541695
Lead Sponsor
University Hospital, Bordeaux
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions